Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response

<div>MIST1 expression in neoadjuvant-/perioperative-treated primary tumors. Ascending intensity of MIST1 expression in tumor cells (a–d). MIST1 is also expressed in inflammatory cells (e) and in cells of the healthy mucosa (f). Original magnifications: 400-fold.</div>

Disease Markers

fig2

Figure 2

Figure 2: Expression of LGR5, FZD7, TROY, and MIST1 in Perioperatively Treated Gastric Carcinomas and Correlation with Therapy Response 